Brief: Boryung Pharm to buy 32.7 pct stake in cell therapy product R&D firm for 1.5 bln won
July 28 (Reuters) - Boryung Pharm 003850.KS Co.,Ltd.:
* Says it will buy 32.7 percent stake (60,000 shares) in a
cell therapy product R&D firm, for 1.5 billion won
Source text in Korean: http://goo.gl/kt2MpA
Further company Coverage: 003850.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +861062674724;
Reuters Messaging: lima.jin.reuters.com@reuters.net))
Recent news on Boryung
See all newsBrief: Boryung Corp Q1 Operating Profit 20.2 Billion Won, Up 84.7% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 20 Billion Won, Up 36% From Year Earlier
Brief: Boryung Corp Q2 Operating Profit 25.4 Billion Won, Up 26% From Year Earlier
Brief: Boryung Q1 Operating Profit 11 Billion Won, Down 33% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 14.6 Billion Won, Down 1.5% From Year Earlier